In this guide
What is grape seed extract?
Grape seed extract is a concentrated preparation from Vitis vinifera seeds, usually marketed for its proanthocyanidins. It is different from grape seed oil, whole grape seed powder, grape skin extract and grapefruit seed extract.
“95% OPC” does not automatically identify a clinically equivalent product. Extraction solvent, molecular-size distribution and assay method can produce different numbers. Apply a trial only to a product that meaningfully matches the tested material.
Typical Grape Seed Extract Protocols
| Source and context | Material | Amount | Frequency | Duration | Observed result |
|---|---|---|---|---|---|
| Park 2016 · adults with prehypertension | Grape seed extract in a 40-kcal beverage | 150 mg per beverage | 2 times daily | 6 weeks after a 2-week placebo run-in | Systolic BP favored GSE; diastolic between-group comparison did not reach significance 36 randomized and 29 completed; blood pressure returned to baseline during the 4-week no-beverage follow-up. |
| Schön 2021 · healthy adults with mildly elevated BP | Enovita white-wine grape seed extract, at least 95% proanthocyanidins by spectrophotometry | 150 mg per tablet | 1 tablet 5–10 minutes before breakfast and 1 before lunch | 16 weeks | Primary between-group systolic and diastolic comparisons were neutral 80 randomized. Favorable male-subgroup and within-group findings were exploratory or secondary. |
| Brooker 2006 · breast induration after radiotherapy | IH636 grape seed proanthocyanidin extract | 100 mg orally | 3 times daily | 6 months | No benefit on the primary induration outcome at 12 months 66 randomized: 44 active and 22 placebo; no significant differences in hardness, appearance, pain or tenderness. |
There is no RDA, AI or UL for grape seed extract. The trial amounts above belong to those formulations and populations.
- Product identity
- Record the botanical source, named extract, extraction method and the method used to report proanthocyanidins.
- Per-administration amount
- Park used 150 mg twice daily; Brooker used 100 mg three times daily. Do not flatten these into an unsupported once-daily schedule.
- Co-delivery
- Park delivered extract in a beverage. Food matrix and energy content can matter when comparing products.
- Outcome window
- Separate the end-of-treatment result from follow-up. In Park, blood pressure returned toward baseline after the product stopped.
Keep the trial attached
“Grape seed extract” is not one interchangeable intervention.
Record the named extract, OPC method and co-ingredients.
Separate milligrams per administration from the daily total.
Between-group primary results outrank favorable within-group changes.
What is grape seed extract commonly used for?
It is commonly marketed for blood pressure, circulation, antioxidant support, swelling, cholesterol and skin health. Human evidence is strongest for intermediate measurements, not for preventing heart attack, stroke or death.
Small favorable studies coexist with neutral trials. A reduction within the active group does not prove treatment benefit unless the change also differs appropriately from placebo.
Which forms and labels matter?
A useful label identifies Vitis vinifera seed, extract ratio or process, amount per serving and a defined proanthocyanidin measurement. “OPC,” “polyphenols” and “proanthocyanidins” are not always measured by the same assay. A high percentage cannot replace a product match.
Grape seed oil is mostly a lipid product and is not a substitute for a proanthocyanidin-rich extract. Grapefruit seed extract is from a different fruit and must never be confused with grape seed extract.
What does the human evidence show?
Park and colleagues randomized 36 adults with prehypertension after a placebo run-in. The active beverage supplied 150 mg twice daily for six weeks. Twenty-nine completed all procedures: 17 placebo and 12 active. Systolic blood pressure improved relative to placebo; the diastolic between-group comparison was a trend rather than conventionally significant. Lipids, glucose, oxidized LDL, flow-mediated dilation and vascular adhesion markers did not significantly improve. Blood pressure returned to baseline after four weeks without the beverage. The small sample and unequal attrition limit certainty. [1]
Schön and colleagues randomized 80 healthy adults with mildly elevated pressure to Enovita 150 mg before breakfast and 150 mg before lunch, or placebo, for 16 weeks. The prespecified between-group comparisons were neutral for systolic pressure (p=0.7197) and diastolic pressure (p=0.2001). The publication highlights favorable changes within the active group and findings in men, but those do not replace the primary treatment-versus-placebo analysis. Several authors were affiliated with the ingredient manufacturer. [2]
Brooker and colleagues tested IH636 100 mg orally three times daily for six months in 66 people with breast induration after radiotherapy. At 12 months, at least 50% reduction in indurated area occurred in 29.5% of the active group and 27% of placebo recipients, a nonsignificant difference. Other assessments of hardness, appearance, pain and tenderness were also neutral. [3]
A meta-analysis of 23 trials found reductions in some oxidative-stress biomarkers but not C-reactive protein or white-cell count. Heterogeneous products, populations and assays make the pooled estimate unsuitable as a universal protocol. [4]
How might grape seed extract work?
Proanthocyanidins and their metabolites can influence oxidation, endothelial signaling and nitric-oxide pathways in laboratory models. Their absorption and metabolism depend on polymer size and gut microbial processing. These mechanisms can justify measurement, but they do not prove prevention of clinical cardiovascular events.
What are the risks and interactions?
Reported effects include headache, nausea, abdominal discomfort, dizziness and dry or itchy scalp. Trial reporting is too small and short to exclude uncommon harms.
Grape seed constituents may affect platelet function or blood pressure. People using anticoagulants, antiplatelet drugs, antihypertensives or multiple cardiovascular medicines should have the exact product reviewed by a clinician or pharmacist. Stop and seek help for unusual bleeding, fainting, facial swelling, breathing difficulty or severe symptoms.
Pregnancy, breastfeeding, pediatric use and long-term high-dose safety are inadequately established. A grape allergy is also relevant.
Legal status in the United States and Canada
In the United States, grape seed extract is sold as a dietary supplement, not an approved treatment for hypertension, fibrosis or cardiovascular prevention.
In Canada, licensed natural health products may have product-specific claims and conditions. A licence does not establish equivalence to Enovita or IH636.
What should be monitored?
Record product, lot, standardization method, amount per administration, frequency, meal timing, blood-pressure technique, symptoms and medicine changes. Use a validated cuff and a consistent procedure if a clinician has asked for home readings.
What happens after stopping?
No withdrawal syndrome or standard taper is established. Park’s follow-up suggests the measured pressure change did not persist after discontinuation. Do not change prescribed blood-pressure medicines based on supplement readings.
How should it be stored?
Keep the original container closed, cool and dry, preserve the lot and expiry data and follow the label. Keep it away from children.
Community experiences
Anecdotes frequently omit the assay used for “OPC,” co-ingredients, cuff method and concurrent medicines. They can suggest what to record, but cannot establish efficacy or interaction safety.
How does grape seed extract compare with other approaches?
Validated lifestyle and medication approaches have clearer cardiovascular-outcome frameworks. Grape seed extract studies mainly measure short-term surrogate endpoints. Grape-derived foods also differ from concentrated extracts and should not be assigned supplement trial effects.
Frequently asked questions
Is grape seed extract the same as grapefruit seed extract?
No. They come from different plants and have different constituents and risks.
Did the 2021 Enovita trial prove lower blood pressure?
No. Its primary between-group systolic and diastolic comparisons were not significant. [2]
What exact schedule did Park 2016 use?
A beverage containing 150 mg was consumed twice daily for six weeks, after a two-week placebo run-in. [1]
Does “95% OPC” guarantee the studied product?
No. The assay and extract process matter, and percentages from different methods may not be comparable.
Does it prevent heart attack or stroke?
The cited trials do not establish fewer cardiovascular events.
Does it help radiation-related breast induration?
IH636 100 mg three times daily did not outperform placebo in the Brooker trial. [3]
Can it be combined with blood thinners?
Have the exact product reviewed because platelet and bleeding effects are plausible and clinical safety data are limited.
Glossary
Terms used in this guide.
- OPC
- A marketing abbreviation commonly used for oligomeric proanthocyanidins; the measured percentage depends on the assay.
- Proanthocyanidins
- A family of flavan-3-ol polymers present in grape seeds and other plants.
- Between-group comparison
- The difference in change between intervention and control groups, usually the key efficacy test.
- Within-group change
- A before-and-after change inside one group that may also reflect time, measurement variation or placebo effects.
- Induration
- Abnormal firmness or hardening of tissue.
- Surrogate endpoint
- A measurement such as blood pressure or a biomarker used instead of a direct clinical outcome.
How this guide was researched
This draft prioritizes three randomized trials with identifiable materials and exact schedules, then uses one meta-analysis to describe biomarker breadth. It preserves null primary outcomes and attrition rather than relying on favorable abstracts. Evidence was updated October 9, 2026.
How this guide was made
The ledger records product identity, amount per administration, frequency, duration, population, primary result, access level, funding context and correction status.
Method and gaps
PubMed identities for Park, Brooker and Foshati were checked against live records. The full open PMC methods and results were read for Schön, including the neutral between-group values. No correction notice was identified in the checked records. Park and Brooker protocol details are from their PubMed abstracts; the full publisher article was not treated as independently reviewed.
Gaps: standardized cross-product comparisons, long-term clinical outcomes, uncommon harms, pregnancy, breastfeeding, pediatrics and reliable interaction incidence.
Sources
Inspect the product-specific trials and the broader biomarker synthesis.
Showing 4 sources
- 01
Effects of grape seed extract beverage on blood pressure and metabolic indices in individuals with pre-hypertension: a randomised, double-blinded, two-arm, parallel, placebo-controlled trial. ↗
Randomized double-blind placebo-controlled trial
36 randomized; 150 mg twice daily for six weeks; systolic between-group result favored extract, with important attrition and no durable follow-up effect.
- 02
Grape Seed Extract Positively Modulates Blood Pressure and Perceived Stress: A Randomized, Double-Blind, Placebo-Controlled Study in Healthy Volunteers. ↗
Randomized double-blind placebo-controlled trial
80 randomized; Enovita 150 mg before breakfast and lunch for 16 weeks; primary between-group blood-pressure comparisons were neutral.
- 03
Double-blind, placebo-controlled, randomised phase II trial of IH636 grape seed proanthocyanidin extract (GSPE) in patients with radiation-induced breast induration. ↗
Randomized double-blind placebo-controlled trial
66 randomized; IH636 100 mg three times daily for six months; primary and secondary outcomes were neutral.
- 04
The effect of grape seed extract supplementation on oxidative stress and inflammation: A systematic review and meta-analysis of controlled trials. ↗
Systematic review and meta-analysis
23 trials in the systematic review and 19 in meta-analysis; some biomarker estimates favored extract, but CRP and white-cell count did not.
No matching sources
Try a different term or show the full list.